LOVASTATIN

Lovastatin is an HMGCoA reductase inhibitor reducing cholesterol synthesis. Benefits include improved lipid profile. Side effects include muscle pain, liver enzyme elevation, and rare rhabdomyolysis. Only GMP materials will be supplied, logistics all according to GDP.

SKU: a47fb7c81233 Category: Tag:

Product Description


Mechanism of Action

LOVASTATIN demonstrates a highcomplexity biochemical profile involving modulation of receptor systems, enzymeregulated metabolic pathways, mitochondrial performance, intracellular ion dynamics and transcriptionlevel regulation. Its structural properties support binding to catalytic and regulatory protein domains, altering phosphorylation cascades, redoxstate equilibrium, cellular stressresponse thresholds and mitochondrial signalling output.

The molecule may influence calcium flux, ATP turnover, ROSantioxidant balance, cytoskeletal organisation and membranepotential stability depending on the biological system and concentration applied.

Benefits and Advantages

Widely applied in mechanistic and pharmacodynamic research, including:

  • Receptorligand interaction analysis and affinity profiling
  • Enzymekinetic and catalyticpathway investigations
  • Mitochondrialfunction, metabolicflux and oxidativestress studies
  • Multiomics research: transcriptomics, proteomics and metabolomics
  • Cellstress signalling, apoptosis/autophagy modelling and cytoskeletaldynamics mapping
  • Preclinical screening, SAR modelling and comparative mechanistic benchmarking

Side Effects and Risks

Potential risks include oxidative imbalance, mitochondrial strain, unintended receptor crossactivation, ionchannel perturbation, metabolic rewiring, and dosedependent cytotoxicity. High exposure may induce apoptosis, autophagy, inflammatory signalling or transcriptional destabilisation. Strict laboratory safety protocols and controlled handling conditions are required.

Only GMP materials will be supplied, logistics all according to GDP.

Datasheet


Molecular Formula

C24H36O5

Molecular Weight

404.5 g/mol

CAS Number

75330-75-5

Storage Condition

Keep container tightly closed in a dry and well-ventilated place. Recommended storage temperature: 2 – 8 °C.

Solubility

Solubility depends on solvent and conditions (e.g., pH). Please contact us for solvent-specific guidance.

Purity

Purity information is available upon request (COA).

Synonym

lovastatin; 75330-75-5; mevinolin; Mevacor; Altoprev

IUPAC/Chemical Name

[(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate

InChl Key

PCZOHLXUXFIOCF-BXMDZJJMSA-N

InChl Code

InChI=1S/C24H36O5/c1-5-15(3)24(27)29-21-11-14(2)10-17-7-6-16(4)20(23(17)21)9-8-19-12-18(25)13-22(26)28-19/h6-7,10,14-16,18-21,23,25H,5,8-9,11-13H2,1-4H3/t14-,15-,16-,18+,19+,20-,21-,23-/m0/s1

References

https://pubchem.ncbi.nlm.nih.gov/compound/53232;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download